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RESEARCH ARTICLE
Four types of scrapie in goats differentiated 
from each other and bovine spongiform 
encephalopathy by biochemical methods
Jan P. M. Langeveld1* , Laura Pirisinu2, Jorg G. Jacobs1, Maria Mazza3, Isabelle Lantier4, 
Stéphanie Simon5, Olivier Andréoletti6, Cristina Acin7, Elena Esposito2, Christine Fast8, Martin Groschup8, 
Wilfred Goldmann9, John Spiropoulos10, Theodoros Sklaviadis11, Frederic Lantier4, Loukia Ekateriniadou12, 
Penelope Papasavva‑Stylianou13, Lucien J. M. van Keulen1, Pier‑Luigi Acutis3, Umberto Agrimi2, Alex Bossers1 
and Romolo Nonno2
Abstract 
Scrapie in goats has been known since 1942, the archetype of prion diseases in which only prion protein (PrP) in 
misfolded state  (PrPSc) acts as infectious agent with fatal consequence. Emergence of bovine spongiform encepha‑
lopathy (BSE) with its zoonotic behaviour and detection in goats enhanced fears that its source was located in small 
ruminants. However, in goats knowledge on prion strain typing is limited. A European‑wide study is presented con‑
cerning the biochemical phenotypes of the protease resistant fraction of  PrPSc  (PrPres) in over thirty brain isolates from 
transmissible spongiform encephalopathy (TSE) affected goats collected in seven countries. Three different scrapie 
forms were found: classical scrapie (CS), Nor98/atypical scrapie and one case of CH1641 scrapie. In addition, CS was 
found in two variants—CS‑1 and CS‑2 (mainly Italy)—which differed in proteolytic resistance of the  PrPres N‑terminus. 
Suitable  PrPres markers for discriminating CH1641 from BSE (C‑type) appeared to be glycoprofile pattern, presence of 
two triplets instead of one, and structural (in)stability of its core amino acid region. None of the samples exhibited BSE 
like features. BSE and these four scrapie types, of which CS‑2 is new, can be recognized in goats with combinations of 
a set of nine biochemical parameters.
© The Author(s) 2019. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creat iveco mmons .org/licen ses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Introduction
Prion diseases or transmissible spongiform encephalopa-
thies (TSEs) are lethal neurological infections in mam-
mals caused by prions from either sporadic, familial or 
transmissible origin [1, 2]. Since the 1980s, a zoonotic 
form of the disease emerged in cattle as bovine spongi-
form encephalopathy (BSE, C-type) through consump-
tion of contaminated meat and bone meal (MBM) [3, 4]. 
BSE was detected in the United Kingdom but later also in 
and outside of Europe although less frequently. In 1995, 
a human variant form of human Creutzfeldt-Jakob dis-
ease (vCJD) emerged with phenotypic similarities to BSE 
[5, 6]. A decennium later, TSE in cattle was differentiated 
by Western blotting in three types of BSE, C-type BSE 
and rare cases of H- and L-type BSE [7–9]. Measures to 
prevent continual feeding of livestock with MBM circula-
tion have led to the near disappearance of BSE and vCJD 
worldwide. Critical herein were also diagnostic post mor-
tem tests with prion protein (PrP) specific antibodies that 
reveal the presence of protease resistant prion material 
that is composed of malformed PrP  (PrPSc) [10]. Aware-
ness and strict surveillance of prion infections remain 
necessary, not only because of the zoonotic and epizootic 
risks of BSE but also other forms of TSE with different 
transmittabilities such as chronic wasting disease (CWD) 
in cervids in North America and South Korea, and newly 
discovered TSEs in cervids in Norway and camelids in 
Algeria [11–13].
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Like other infectious agents, prions also exist as strains. 
Their transmissibility depends uniquely and largely on 
the amino acid sequence of normal cellular PrP  (PrPC), 
and possibly on host factors during conversion of  PrPC to 
 PrPSc [14]. Strain characteristics are phenotypical proper-
ties such as incubation time, lesion profile, and variations 
in deposition and molecular features of  PrPSc. Multi-
ple strains from scrapie in sheep have been described in 
rodent bioassays, while bovine BSE behaves as a single 
strain [1, 5, 15].
However, in goats strain typing efforts have rarely been 
reported [16–18]. While scrapie in sheep is known to 
have existed for centuries, there are no indications that 
under natural conditions other species are infected by 
scrapie except goats. The source of the BSE epidemic is 
still uncertain, but plausible explanations are that it has 
evolved from small ruminant scrapie or from a sporadic 
case of BSE in cattle [3, 9]. Sheep and goats are known to 
be susceptible to BSE, but in the field only two cases in 
goats have been reported and these most probably origi-
nated from ingesting BSE contaminated feed [19–21].
Before deciding to carry out strain typing bioassays in 
rodents with their long lasting incubation times, ELISA 
and Western blotting (WB) with infected brain samples 
are important to rapidly classify scrapie like TSE types1 
and to exclude the presence of BSE [22–30]. In sheep, 
scrapie occurs in different biochemical types such as clas-
sical scrapie2 (CS), atypical/Nor98 scrapie (AS) and a rare 
form of CS, CH1641 scrapie. Proteolytic digestion with 
proteinase K (PK) of the  PrPSc aggregate and its subse-
quent unfolding and dissociation are essential for binding 
by PrP  site-specific antibodies. CH1641 scrapie exhibits 
similarities with BSE since in both types distinct N-termi-
nal PrP epitopes are protease sensitive [31]. In addition, 
mixtures of TSE forms could be present in a single ani-
mal, which hamper recognition of low BSE levels [32].
During 2004–2014, we collected over seventy TSE goat 
brain samples from seven European countries based on 
various criteria such as tissue quality, geographical dis-
tribution, breed, PRNP genotype. From this unique col-
lection, over thirty goat TSE isolates from seven EU 
countries have been subjected to biochemical TSE-typ-
ing. These samples were probed by ELISA and Western 
blotting for the presence of different sequence domains 
in  PrPSc under different conditions of pre-treatment and 
proteolysis when preparing its proteinase K (PK) resist-
ant domain  (PrPres). Samples such as CS, AS, BSE and 
CH1641 scrapie served as references. These materi-
als are also under strain typing investigation by rodent 
bioassays.
Materials and methods
Antibodies
PrP-specific monoclonal antibodies (mAbs) used 
in this study were L42 and P4 (R-Biopharm, Ger-
many), Sha31, SAF84, SAF34 and Bar224 (SpiBio, 
France), and 12B2 and 9A2 (WBVR, Lelystad, Neth-
erlands). The mapped epitope amino acid sequences 
(sheep PrP numbering, [33]) determined by immo-
bilized multi-peptide analyses are: 70QPHGGGW76 
(SAF34), 93WGQGGSH99 (P4), 93WGQGG97 (12B2), 
102WNK104 (9A2), 144FGSNDYEDRYYR154 (Bar224), 
148YEDRYY153 (L42), 148YEDRYYRE155 (Sha31), and 
167YRPVDQY172 (SAF84) [34–38].
Animals and tissues
During 2004–2012, we collected over seventy TSE goat 
brain samples from seven European countries fitting the 
EU rules EC No. 999/2001 for TSE surveillance. As study 
samples a selection of 32 of these field cases was chosen 
together with two confirmed negatives (study codes G15, 
G17), and three experimentally infected goats: orally 
challenged with goat scrapie (F11), goat intra-cerebrally 
(i.c.) inoculated with sheep scrapie (F2) and i.c. inocu-
lated with bovine BSE (ic-gtBSE1) (Table 1). The selection 
was based on criteria such as tissue quality, genotype, 
broad geographical distribution, and potential type 
variation. Tissues used consisted mainly of brain stem 
obtained at slaughterhouses or at euthanasia of experi-
mentally infected animals. The national identity code, 
country of origin, breed, age and PrP genotype of the 
samples were recorded. Only the samples from United 
Kingdom, Netherlands, and two Greek cases (G13, G16) 
originated from single holdings.
In addition, infected goat brain materials from other 
studies were investigated derived from animals infected 
i.c. with scrapie (n = 6) and orally or i.c. with BSE 
(n = 9) [39, 40]. As occasional reference controls were 
included experimental sheep and goat BSE, ovine CS 
(n = 2), bovine BSE, caprine AS, and i.c. raised CH1641 
material from sheep (n = 2) and goat, and an ovine 
CH1641-like field case (see Additional file 1). The animal 
experiments to obtain these materials were performed 
at WBVR according to European directive 2010/63/
EU and in agreement with the Dutch Central Authority 
1 “TSE type” is used for phenotypic observations in infected tissues based 
on microscopic or test tube experiments. “Strain type” is used as the out-
come from passaging of infected tissue in another host, usually rodents such 
as inbred mouse or bank vole lines, or transgenic mice expressing PrP from 
another species.
2 In biochemical terms, classical TSEs yields in Western blot analyses a tri-
plet of  PrPres bands consisting of a di-, mono-, and non-glycosylated (resp. 
D, M and N) PrP fragment of similar amino acid sequence. For clarity in the 
use of uppercase N: non-glycosylated will be written with a regular capital 
N and amino terminus with the italics description N-terminus.
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Table 1 Goat sample codes and details and final outcome of the TSE typing study 
Study codes will be used in the text reflecting the country of origin, I for Italy, N Netherlands, F France, S Spain, G Greece, C Cyprus, UK United Kingdom. From single 
holdings were only the cases from Netherlands, UK and Greek cases G13 and G16. Symbols: *, obtained after experimental infections (see “Materials and methods”). 
The specific tests performed on the samples, the  PrPres content of the sample (when analysed in Triplex-WB) are presented in Additional file 2.
a INRA, Institut National de la Recherche Agronomique. ? = region of origin or age not disclosed or not known.
b Genotype as defined by specific polymorphic codon positions in the goat PRNP gene. Wild type (wt) is defined as follows: 127GG, 142II, 143RR, 154RR, 211RR, 
222QQ, 240SS. Unless wt genotype, only the codon positions that differ from homogenous wild type are shown.
c Samples F14 and G2: probably CS-1. F14 too weak for Triplex-WB and ISS-PK methods, G2 too little amount for distribution. G12 and UK-D2: late samples, only 
analysed by Triplex-WB, too weak signal for analysis.
Study code Country Identity # Breed  [region]a Age (year)a Genotypeb Molecular TSE-type
STUDY CASES
I2 IT 114921/1/1 Camosciata [Piedmond] 10 240PP CS‑2
I3 121429/1/1 Meticcia [Sicily] 5 240PP CS‑2
I4 128710/1/1 Saanen [Lombardy] 3 211QR, 240PS CS‑2
I5 17646/1/1 Meticcia [Sicily] 5 240PP CS‑2
I7 85788/1/1 Meticcia [Sicily] > 1.5 240PP CS‑2
I9 85792/1/1 Meticcia [Sicily] 6 143HR, 240PS CS‑2
I11 117463/1/1 Meticcia [Emilia‑Romagna] 9 240PS CS‑2
I12 144508/1/1 Alpina [Apulia] 5 240PS CS‑2
I15 87016/1/1 Meticcia [Campania] 6 154RH, 240PS AS
N1 NL 577277 Dwarf goat [Limburg] 2–3 143HR, 240PS CS‑1
N2 586632‑32 Dwarf goat [Limburg] ? 240PP CS‑1
N3 586632‑33 Dwarf goat [Limburg] ? 143HR, 240PS CS‑1
F2* FR CP40 Saanen [INRA] 4 240PS CS‑1
F3 CDP1028 Saanen [Poitou] 5 240PP CS‑1
F6 CP2119 Saanen [Charentes] 3–4 240PS CS‑1
F10 CP/2143 Alpine [Limousin] 3–4 240PS CS‑1
F11* CP2154 Saanen [Poitou] 4 142IM, 240PP CS‑1
F14 CP9041 Alpine [Poitou] 6 142IM, 240PS CS‑1c
F16 CP9135 Alpine [Indre] 6 240PS CS‑2
ic‑gtBSE1* CH1075 Saanen [INRA] ? 211RQ, 240PS BSE
S2 SP C‑163P Alpine [Asturia] 6 240PS CS‑1
S3 C‑645P Crossbreed [Aragon] 4 240PP CS‑1
G2 GR 1663 Capra prisca [Macedonia] ? 240PP CS‑1c
G3 1676 Capra prisca [Macedonia] 4 143HR, 240PP CS‑1
G11 GR005 Capra prisca [Larissa] 6 211RQ, 222QK CS‑1
G12 GR177 Capra prisca [Larissa] 4 222QK <c
G13 GR018 Capra prisca [Larissa] 5 wt CS‑1
G14 GR055 Capra prisca [Ioannina] 4 wt CS‑1
G15 GR195 Capra prisca [Kozani] 2.5 222QK NEG
G16 GR091 Capra prisca [Thessaloniki] 2 wt CS‑1
G17 GR247 Capra prisca [Evros] 4.6 222QK NEG
C1 CYP Zyp13 Damascus [Nicosia] 4 240PP CS‑1
C2 Zyp21 Damascus [Nicosia] 5 240PP CS‑1
C3 Zyp27 Damascus [Nicosia] 3 wt, 240PP CS‑1
UK‑A2 UK G08‑1475 Anglo‑NubianxSaanen [?] 4 127GS, 240PP CS‑1
UK‑B2 G08‑1469 Anglo‑NubianxSaanen [?] 8 127GS, 240PP CS‑CH1641
UK‑C2 G08‑1460 Anglo‑NubianxSaanen [?] 9 127GS, 240PP CS‑1
UK‑D2 G08‑1446 Anglo‑NubianxSaanen [?] 7 211RQ, 240PP <c
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for Scientific Procedures on Animals, permit number 
AVD401002016522.
Fifty percent macerates in water were prepared under 
TSE sterile conditions. Samples were weighed, immersed 
in an equal part of water, minced, and left for 18  h at 
4  °C. Material was ground in a Pyrex glass Dounce to a 
homogenous paste, further forced several times through 
a 19G needle, and finally stored in aliquots at −80  °C. 
These macerates were dispatched to the participating lab-
oratories. Depending on the analysis and the timely avail-
ability of tissue, the set of samples used per study differed 
(see Additional file 2).
CEA-ELISA (performed at CEA: Commissariat à l’énergie 
atomique et aux énergies alternatives)
A discriminatory ELISA for detecting BSE in small rumi-
nants followed procedures as described [28]. Each sam-
ple was treated in two ways which is proteinase-K (PK) 
digestion in normal condition A (Biorad proprietary 
detergent and chaotrope concentrations, 0.04  mg  mL−1 
PK) and denaturing condition Aʹ (5% [w/v] N-lauroylsar-
cosine sodium salt, 5% [w/v] sodium dodecyl sulphate, 
0.11 mg mL−1 PK (Aʹ/A). Negatives do not show a  PrPres 
signal. The following normalised ratios Aʹ/A are indica-
tive for CS, BSE and AS respectively > 1.43, between 
0.78–1.43 and below 0.78.
ISS-WB procedure for discrimination between classical 
scrapie and BSE (performed at ISS: Istituto Superiore di 
Sanità)
To discriminate between classical scrapie and BSE, the 
ISS discriminatory Western blot procedure (ISS-WB) 
was used. This test uses 0.2 mg mL−1 PK for digestion and 
antibodies P4 (0.4 µg IgG  mL−1) and SAF84 (0.8 µg IgG 
 mL−1) for detection. Data were collected with a chemo 
luminescence imager (VersaDoc, Bio-Rad) and quantified 
as in TSE EU Reference Laboratory manual. Two deci-
sive cut-off values for BSE are applied: in BSE samples 
the P4/SAF84 ratios should be < 0.5 and molecular mass 
of the non-glycosylated  PrPres band (N, see footnote 2 for 
the triplet terms N, M and D) based on SAF84 < 0.5 kDa 
compared to that of internal control (sample I11) [41, 42].
IZSTO-WB procedure for detection of Nor98/atypical 
scrapie (AS) (performed at IZSTO: Istituto Zooprofilattico 
Sperimentale del Piemonte at Torino)
Digestion with proteinase K (PK) and Western blotting 
(WB) using a chemo luminescence imager (ChemiDoc, 
Biorad) for data collection were followed as described 
before, except that for AS cases PK was used at 0.02 
instead of 0.04  mg  mL−1 [43]. Antibodies used were 
12B2, 9A2, Sha31 and SAF84 respectively at concentra-
tions 0.2, 0.2, 0.1 and 1 µg IgG mL−1.
Triplex-WB procedure (performed at WBVR: Wageningen 
BioVeterinary Research)
PK was used at 0.05 mg mL−1, and WB performed with 
a mix of antibodies 12B2, Sha31 and SAF84 on a sin-
gle membrane at concentrations of respectively 0.2, 0.1 
and 0.5 µg mL−1 IgG. Calculations on resulting fluores-
cent antibody signals were carried out with ImageQuant 
software exactly as before [44]. The fluorescence of the 
mAbs with respective Zenon labels Alexa647, Alexa488 
and Alexa555 (InVitrogen) was normalized to 1 based on 
recombinant  ovPrPARQ on each gel. Molecular masses 
of  PrPres bands D, M and N (see footnote 2 for triplet 
band nomenclature) were estimated with Gel-Pro ana-
lyser software (Media Cybernetics) using as reference 
SeeBlue dye markers which are visible at 647 nm. Sam-
ples were analysed in triplicate. Parameters calculated 
from the Image Quant software figures such as molecu-
lar masses, 12B2/Sha31 ratios, M/D ratios, D-, M-, and 
N-fractions, and SAF84/Sha31 ratios at the 24 kDa  PrPres 
fraction yielded per sample standard deviations below 
respectively 4, 27 16, 5, 12, 23 and 17 in percentage of the 
average.
Raising PK concentration to 1 mg mL−1 for  PrPres 
preparation (ISS-PK)
To investigate the PK susceptibility of CS cases, a new 
approach used a high concentration of PK (1 mg mL−1), 
or in some cases a range of PK concentrations between 
0.02 and 4 mg mL−1 PK, followed by ISS-WB. After PK 
digestion at 1  mg  mL−1, the P4/SAF84 ratio was calcu-
lated for each sample, relative to the ratio of an internal 
control (sample I11).
Guanidine-treatment (ISS-Gdn)
To differentiate CS and CH1641-like isolates from 
small ruminant BSE a method to test structural sta-
bility of the  PrPSc core was used [27]. The protocol 
(ISS-Gdn) included a pre-treatment with 3.5  M guani-
dine-HCl (Gdn). Equal aliquots of a sample were either 
left untreated or treated for 1 h at 37 °C and then adjusted 
to a final concentration of 0.35 M Gdn, and digested with 
0.2  mg  mL−1 PK. ISS-WB with PrP-core specific mAb 
SAF84 was used for detection. Stability of  PrPres core was 
reflected in the antibody binding signal ratios obtained at 
3.5 and 0 M Gdn (3.5 M/0 M).
High pH/PK treatment (WBVR-pH8)
Another method to test  PrPres core structural stabil-
ity consisted of two digestion conditions where one ali-
quot of sample was digested at 50  µg  mL−1 PK/pH  6.5 
and another aliquot at 500  µg  mL−1  PK/pH  8 [26]. WB 
was performed with PrP core specific antibody L42 
(0.2  µg  IgG  mL−1) and chemo luminescence detection. 
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Antibody signals on films were estimated as before [9]. 
The relative stability of the  PrPres core was expressed as 
the pH8/pH6.5 signal retention ratio between each set of 
aliquots.
Statistical analyses
With statistical software (GraphPad  Prism® 8), one-way 
ANOVA compared three or more unmatched groups, 
based on the assumption that the populations were 
Gaussian. When P values were ≤ 0.05, means were con-
sidered to be derived from non-identical populations. In 
that case, one-way analysis of variance was used to estab-
lish whether differences between groups of data were 
greater (P ≤ 0.05) than expected using Bonferroni–Dunn 
t-test.
Results
Analyses to discriminate between BSE, classical scrapie 
and Nor98/atypical scrapie
Initial analyses were carried out by CEA-ELISA on goat 
samples from all countries except on those from UK 
and G11–G17 from Greece. Most fields cases scored as 
CS with Aʹ/A ratios > 1.43, except for sample I3 which 
showed a borderline BSE value of 1.35 and sample I15 a 
ratio of 0.05 indicative for AS-like scrapie (Figure  1A). 
All experimental CS and BSE samples including ic-
gtBSE1 resulted in values as expected for CS and BSE, 
respectively.
In ISS-WB analysis (see Additional file  3), most field 
cases fulfilled the two criteria for CS except for samples 
UK-B2 and I15 (Figures 1B and C). UK-B2 exhibited BSE-
like features by showing both a low N-terminal epitope 
 PrPres content (P4/SAF84 signal ratio < 0.5) and N-band 
 PrPres molecular mass > 0.5 kDa lower than that of the CS 
reference I11.
The  PrPres banding pattern of sample I15 was as in 
AS-like samples with a major band at 8 kDa, when using 
antibody P4, while SAF84 did not show binding (see 
Additional file 3). This was further confirmed in IZSTO-
WB with mAbs 12B2, 9A2, Sha31 and SAF84 (data not 
shown).
Triplex-WB: three-antibody analysis on a single membrane
Triplex-WB can yield on one membrane quantifications 
of molecular properties of  PrPres from the signals of a mix 
of three mAbs which are in this study 12B2, Sha31 and 
SAF84 (Figure 2).
Similar results were obtained as above with ISS-WB 
but now they were estimated relative to the Sha31 sig-
nal instead to SAF84. The results can be summarized as 
follows:
1. in all but one case a high N-terminal epitope con-
tent with 12B2/Sha31 ratios between 0.3 and 1.2 
were seen, the exception being UK-B2 (0.1, BSE-like) 
(Figure 3A); interestingly, the Italian samples as well 
as F16 and UK-A2 were the lowest in 12B2 epitope 
content (between 0.3 and 0.9) similar to what was 
observed with P4 in the ISS-WB (see Additional 
file 4). The N-terminal epitope content of this group 
of samples was in both WB systems statistically lower 
than of other CS samples and higher than of the BSE 
samples (P < 0.001).
2. a glycoprofile with M/D ratios > 0.3 can be observed 
in all study samples including UK-B2, gtCH1641 
and shCH1641 due to a low D fraction in contrast 
to ratios ≤ 0.2 in BSE with high D levels. Addition-
ally, the N band fraction was higher in all CS samples, 
including CH1641, than in BSE (Figure 3B).
3. molecular masses of the  PrPres N-fraction in the 
CS cases ranging from 19.3 to 21.6  kDa, and those 
of BSE, CH1641 and UK-B2 from 18.7 to 19.4  kDa. 
There was a reasonable linear regression correlation 
between N-terminus epitope content of (N + M + D 
bands) and the molecular mass of the N band 
 (R2 = 0.602, see Additional file 5).
Banding patterns of Sha31 and SAF84 in UK-B2 were 
different from CS and BSE samples, but similar to that 
of control samples C-shCH1641 and C-gtCH1641 in 
which typically two  PrPres triplets were present (tri-
plet #1 bands D1, M1 and N1, triplet #2 bands D2, M2, 
and N2 in Figure 2). Of these two triplets, one migrated 
between 18 and 29  kDa similar to that obtained with 
mAb Sha31  (PrPres#1), and the other between 10 and 
24 kDa  (PrPres#2) only bound by SAF84 (see Additional 
file 6). Proof for presence of such double triplet composi-
tion could be confirmed by using at 24–25 kDa signal of 
the SAF84 and Sha31 fractions in the 18–29 kDa region 
(ratio SAF84/Sha31 at 24 kDa), which in case of CH1641 
yields a value around two while single populations are 
around one. All BSE and CS samples varied around one 
(range 0.8–1.2) (Figure 3A).
PK sensitivity of  PrPres N-terminal epitope of CS cases
The PK-sensitivity of the  PrPres N-terminus of CS cases 
in the two WB methods (see Additional file  4) was fur-
ther tested by stepwise increasing the PK concentration 
from 0.02 to 4 mg PK  mL−1 in several samples compar-
ing the relative binding of P4 and SAF84 epitopes (Fig-
ures 4A and B). After confirming the reproducibility, all 
CS samples were subjected to one single PK digestion 
at 1  mg  mL−1 to estimate the P4/SAF84 ratio (ISS-PK 
method). All Italian samples and F16 were clearly below 
a ratio cut-off value of 1.4 and considered as a separate 
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group of CS type. These biochemical groups are here 
defined for > 1.4 and < 1.4 as type CS-1 and CS-2 respec-
tively (Figure 4C).
Structural stability of total  PrPres
We also investigated the PK resistance of the  PrPres core 
region as an indicator of structural stability. This was car-
ried out with two different approaches and WB to probe 
the effect.
After 3.5  M Gdn-HCl pre-treatment in the ISS-Gdn 
method, core epitope loss was probed by ISS-WB to 
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Figure 1 Discriminatory test results for exclusion of BSE in goat samples. Values below red broken lines indicate that sample concerned 
is considered BSE suspect. A CEA‑ELISA. Values are normalised to sample ic‑gtBSE2. B, C ISS‑WB results (see Additional file 3). In B are shown 
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measure the SAF84 signals at 3.5  M relative to that 
without pre-treatment. All CS study cases and CH1641 
specimens were quite sensitive for PK digestion with 
3.5 M/0 M ratios lower than 0.35 (i.e. > 65% core epitope 
loss) including UK-B2 (89% loss), while BSE samples 
were significantly more resistant with less than 45% loss 
(Figure 5A).
The WBVR-pH8 method compared high and nor-
mal pH during PK digestion. Expressed by the L42 sig-
nal ratio pH8/pH6.5, this yielded low and high retention 
ratios for CS and BSE, respectively (Figure  5B). While 
the CS cases on average lost around 62% (ratio < 0.38) of 
antibody binding, the goat BSE sample showed the lowest 
loss of binding up to only 36% (ratio > 0.64). A reference 
sample of sheep scrapie showed higher signal loss than 
sheep BSE—56% compared to 15%—in line with what 
had already been observed before [26].
Discussion
The combined efforts in different laboratories, which 
shared the same goat brain macerates, enabled a thor-
ough investigation using various chemical pre-treatments 
and subsequent biochemical analyses to clearly establish 
that none of the field cases was BSE.
On the other hand, the combined biochemical evi-
dence from over 30 different field cases of prion disease 
collected from seven different European countries shows 
clearly that in goats similar types of scrapie occur as in 
sheep, which are atypical/Nor98 (AS) scrapie and several 
forms of classical scrapie (CS). Potentially three types of 
CS could be discriminated differing in increasing order 
of protease sensitivity of the N-terminus of  PrPSc: CS-1 
occurring most frequently, CS-2 occurring—but prob-
ably not only—in Italy, and one unambiguous CH1641-
like case found in a scrapie infected herd in the United 
Kingdom (see column Molecular TSE-type, Table 1).
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Biochemical parameters for typing TSEs
In this study, nine different molecular  PrPres parame-
ters appeared useful to discriminate TSE types in brain 
homogenates of native goat samples (Table  2). These 
were glycoprofile (M/D and %N), PK resistance of the 
N-terminus (three approaches), molecular mass of  PrPres 
bands (reflected in the non-glycosylated fraction), dou-
ble triplet composition, core sequence stability and—for 
AS—absence of a C-terminal fragment covering roughly 
the 154–234 PrP sequence corroborating a previous 
study [45].
One of these parameters is a new candidate and 
dependent on a 1 mg mL−1 PK treatment that effectively 
leads to differentiation between the CS subclasses CS-1 
and CS-2. While in the three tests using Western blotting 
(ISS-WB, Triplex-WB and ISS-P with high PK concen-
trations) the difference in PK susceptibility of the  PrPres 
N-terminal domain was obvious this was not the case in 
the ELISA. The explanation could well be that the ELISA 
is dependent on the presence of a more N-terminally 
located epitope between PrP amino acid residues 70–76 
used in the ELISA compared to the P4 and 12B2 epitopes 
in these three WB tests which epitopes are located more 
down stream the PrP-sequence i.e. between residues 
93–97. The ELISA is therefore more sensitive for removal 
of N-terminal amino acids at sites in the 70–93 amino 
acid region of PrP, which might be helpful in finding the 
deviant cases but not to recognize truly BSE-like cases.
For differentiating CS-CH1641 from BSE several robust 
parameters were available which are the two glycoprofile 
markers M/D ratio and percentage of the N-fraction, 
structural stability and the unique presence of two  PrPres 
triplets.
Are biochemically distinct classical scrapie types related 
to different strains?
The different  PrPres signatures of the CS-1, CS-2 and 
CS-CH1641 cases might have at least two different ori-
gins. One would be that it is a host dependent phenom-
enon in which a common scrapie strain in certain hosts 
shows up with a  PrPres triplet property as observed under 
the current biochemical treatments for diagnosis. In this 
case, the host is determining the biochemical phenotype 
of the strain by yet unknown factors. The other possibil-
ity could be that the phenomenon is a real strain prop-
erty, which in the particular in case of CS-CH1641 is 
even rarely observed in sheep and goats. If so, it should 
be possible to make scrapie strain types visible in trans-
genic mice with various ovine (or caprine) PRNP expres-
sion levels [46]. Also, the effect of PrP polymorphisms 
need to be considered. To figure this out quite a number 
of rodent models are nowadays available to enable such 
typing studies.
Significance of TSE-type for resistance breeding 
and polymorphisms
As with sheep, rapid typing of potential TSE agents in 
goats is necessary since different types can have dif-
ferent genetic susceptibilities [47, 48] or even different 
zoonotic potential [49]. Resistance/susceptibility to TSEs 
in mammals including the human species is dependent 
on genetic variation in the PRNP gene coding sequence 
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Gdn‑HCl treatment on susceptibility to proteolytic degradation was 
compared to normal condition when analysed by ISS‑WB with mAb 
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(Bonferroni–Dunn method).
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[50–53]. In goats this polymorphism variability is partly 
similar to that in sheep and currently at least 51 cod-
ing polymorphisms have been described in goat [54]. In 
our set of field cases goats with several PRNP genotypes 
were selected (Table  1), including two scrapie positive 
goats (G11 and G12) carrying a scrapie resistance related 
lysine at codon 222 in heterozygosity both of which con-
tained very low  PrPres levels (see Additional file 2). How-
ever, there appeared to be no association between the 
variability in biochemical characteristics of  PrPres and 
PRNP genotype in this study. Breed of animals could be 
another reason for phenotypical variability but although 
the breed of most animals was known it is not possible 
to connect this information to our results by lack of suf-
ficient samples and because within the breed itself PrP 
polymorphism distribution can greatly differ [55, 56].
Geographical differences
Little is actually known about geographical differences 
with respect to the occurrence of prion strains. In this 
study on goats from seven European countries—Italy, 
France, Greece, Cyprus, Spain, Netherlands and United 
Kingdom—material was collected and distributed to 
participating partners from single macerates. From our 
stability experiments, PK treatments and the two dif-
ferent antibody combinations (P4/SAF84 and 12B2/
Sha31/SAF84) used in the WB analyses, CS-2 is an 
example of geographic variation of scrapie types. This 
form does occur mainly both in mainland Italy and Sic-
ily, and possibly also sometimes in other countries such 
as France (example F16). Whether this CS-2 type has 
a source in Italy in the use of a vaccine against Myco-
plasma agalactiae in both goats and sheep during the 
late 1990s is a possibility [57]. CS-1 might have existed 
before in Italy, but maybe the vaccination strain has 
become the dominant one.
Prospects
Similarities between sheep and goats in genetics and 
the prion protein sequence itself were also encountered 
in the TSE types discerned in this study on goat scra-
pie field cases. Our consortium will report separately 
whether these biochemical typing studies in the macer-
ates are linked to any strain type after first passage in 
an unprecedented broad set of rodent models. So far 
Table 2 PrPres parameters that differentiate TSE-types in goats 
Nine parameters of  PrPSc obtained after differential PK digestion of TSE infected goat brain and WB. Epitope location determines the outcome. The italic texts indicate 
differences between CS-1 and CS-2. Between parentheses are the ranges in quantitative values as obtained in Triplex-WB (Sha31 related), ISS-WB (SAF84 related) or 
ELISA (SAF34 + Bar224 related). The ranges are relative to the different categories, not absolute, and should be compared per experiment with proper controls (BSE, 
CS-1, CS-2, CS-CH1641). ND: analysis not done, NA: not applicable due to absence of a classical  PrPres triplet. These typing tests may well work also on sheep TSE 
samples
a Glycoprofile estimated by ISS-WB with SAF84 did show similar discriminatory properties as with Sha31 for C-1, CS-2, and CH1641 M/D values > 0.4 and BSE < 0.4, and 
N percentages for CS > 13% and BSE < 13%
b Result with 12B2/Sha31 from Triplex-WB, P4/SAF84 from ISS-WB and SAF34 + Bar224 from CEA ELISA
c These two rows represent the same differentiating parameter. Differences between ISS-WB and Triplex-WB in molecular mass values are due to use of different gel 
systems and molecular mass standards
d Absence of PrP region ~ 154–234 is based on presence of Sha31 epitope and absence of SAF84 epitope corroborating interpretations by Pirisinu et al. [45]
e The molecular mass of the N-fraction of  PrPres#1 triplet is estimated to be 18.5 kDa, and that of the  PrPres#2 triplet 10 kDa (see Figure 2).
PrPres parameter CS-1 CS-2 CS-CH1641 BSE AS
Glycoprofilea
 M%/D% ratio, Sha31 High (> 0.3) High (> 0.3) High (> 0.3) Low (< 0.2) NA
 N%, Sha31 High (> 8%) High (> 8%) High (> 8%) Low (< 8%) NA
N‑terminus  levelb
 Normal PK: 12B2/Sha31 ratio High (0.8–1.3) Interm. (0.3–0.7) Low (< 0.2) Low (< 0.2) NA
 High PK: P4/SAF84 ratio High (1.4‑4) Interm. (0.2–1.3) ND ND NA
 High PK: A’/A ratio, SAF34 + Bar224 High (> 0.3) High (> 0.3) ND Low (0.8–1.3) minute (≪ 0.8)
kDa (N‑band)c
 Triplex‑WB, Sha31 19.9–21.6 19.3–20.6 18.5–19.5e 18.5–19.5 NA
 ISS‑WB, SAF84 17.5 17.5 16–17 16–17 8
Triplet profile, SAF84/Sha31 ratio at 22– 24 kDa Single Single Double Single Absent
Core stability: SAF84 and L42 Low Low Low High NA
PrP C‑terminus ~ 154–234d Present Present Present Present Absent
Page 11 of 13Langeveld et al. Vet Res           (2019) 50:97 
it seems, that the CS-2 cases also in the rodent models 
point to a separate strain that underscores the impor-
tance of further developing biochemical tools for TSE 
type discrimination [58].
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